Essential Thrombocythemia Clinical Trials

Find Essential Thrombocythemia Clinical Trials Near You

MPNdpoint. Single-center, Retrospective, Prospective Study of the Outcome of Patients With Philadelphia-negative Chronic Myeloproliferative Neoplasms

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Chronic myeloproliferative neoplasms (MPNs) are hematologic disorders of the myeloid lineage characterized by clonal proliferation of hematopoietic stem cells, high risk of thrombotic-hemorrhagic complications, and transformation into secondary acute myeloid leukemia. MPNs include: myelofibrosis, polycythemia vera, and essential thrombocythemia. The low incidence, comparable to that of rare diseases, induces the in-depth study of patients and thus the need to develop a project with databases to collect clinical, biological, and therapeutic information.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 16
Healthy Volunteers: f
View:

• Patients 16 years of age and older

• Patients diagnosed with polycythemia vera, essential thrombocythemia, prefibrotic and overt primary myelofibrosis, secondary myelofibrosis (Arber et al, Blood 2022 or earlier but reclassified classifications)

Locations
Other Locations
Italy
Ospedale Maggiore Policlinico
RECRUITING
Milan
Contact Information
Primary
Barbara Mora, MD
barbara.mora@policlinico.mi.it
+39 0255033345
Time Frame
Start Date: 2025-02-17
Estimated Completion Date: 2044-06
Participants
Target number of participants: 1190
Sponsors
Leads: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

This content was sourced from clinicaltrials.gov

Similar Clinical Trials